| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229433 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | DE102010012223A1 Pharmaceutical preparation, useful for the treatment of autoimmune disease, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, Crohn's disease or ulcerative colitis, comprises 12-imidazolyl-1-dodecanol |
| 09/22/2011 | CA2793657A1 Myeloid derived suppressor cell inhibiting agents |
| 09/22/2011 | CA2793458A1 System and method of preparing and storing activated mature dendritic cells |
| 09/22/2011 | CA2793125A1 New enzyme inhibitor compounds |
| 09/22/2011 | CA2792956A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366713A2 Polypeptide variants with altered effector function |
| 09/21/2011 | EP2366707A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366407A1 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 09/21/2011 | EP2366394A1 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase IV (DP IV) |
| 09/21/2011 | EP2366391A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366390A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365818A2 Hypoallergenic dermatological composition |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2351764A8 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/21/2011 | EP2215082B1 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists |
| 09/21/2011 | EP1966202B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | EP1073905B1 Methods of selecting internalizing antibodies |
| 09/21/2011 | CN1468089B Microparticles for delivery of the heterologous nucleic acids |
| 09/21/2011 | CN102197052A High affinity human antibodies to human IL-4 receptor |
| 09/21/2011 | CN102197038A Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 09/21/2011 | CN102196810A Pharmaceutical composition improved in absorption through intestinal tract |
| 09/21/2011 | CN102196733A Method for concentrating lipid |
| 09/21/2011 | CN102191305A Preparation method of hoof nail polypeptide through composite hydrolysis |
| 09/21/2011 | CN102191153A Burdock-water caltrop pulp health wine and production method thereof |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102190713A Synthetic peptide and application thereof |
| 09/21/2011 | CN102190669A Dihydro pteridinone derivatives, preparation method thereof and application thereof in medicines |
| 09/21/2011 | CN102190659A Phenylpyrazine compounds, and preparation method and medicinal application thereof |
| 09/21/2011 | CN102190633A Cetirizine derivatives, and composition and application thereof |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188700A Improved bacterial outer membrane vesicles |
| 09/21/2011 | CN102188684A Chinese medicinal acupoint application plaster for treating allergic rhinitis and preparation method thereof |
| 09/21/2011 | CN102188660A Chinese medicinal health-care medicinal liquor |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188628A Nutrition tablets for tonifying kidney, strengthening yang and enhancing immunity for men, and preparation method thereof |
| 09/21/2011 | CN102188543A Tea polyphenol tablet and preparation method thereof |
| 09/21/2011 | CN102188536A Method for preparing Radix Astragali rehmanniae radix particles |
| 09/21/2011 | CN102188523A Plant antibiotic |
| 09/21/2011 | CN102188489A Composition containing fructus broussonetiae extract for strengthening immune function |
| 09/21/2011 | CN102188467A Traditional Chinese medicine composition for reinforcing vital energy and consolidating constitution, boosting human immunity, resisting fatigue and tumor, and delaying aging |
| 09/21/2011 | CN102188458A Method for extracting triterpenoids from pleurotus eryngii strain residues |
| 09/21/2011 | CN102188455A Method for extracting totipotent propolis |
| 09/21/2011 | CN102188448A Pilose antler freeze-dried excipient with smooth appearance and production method thereof |
| 09/21/2011 | CN102188370A Resveratrol injection solution and intravenous injection |
| 09/21/2011 | CN102188135A Chinese medicine pillow for preventing and treating cold |
| 09/21/2011 | CN101912221B Multipurpose traditional Chinese medicine health care drug pillow |
| 09/21/2011 | CN101708215B Method for extracting triterpenes from schisandra chinansis |
| 09/21/2011 | CN101606963B Traditional Chinese medicine combination for enhancing disintoxication and improving dyscrasia of cancer patients |
| 09/21/2011 | CN101485692B Method for pressing spirulina special-shaped tablets |
| 09/21/2011 | CN101389612B 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/21/2011 | CN101332259B Cordycepin polysaccharide buccal tablet and preparation method thereof |
| 09/21/2011 | CN101327268B Oral chinese medicine for treating solar urticaria |
| 09/21/2011 | CN101306096B Decoction for treating chronic eczema |
| 09/21/2011 | CN101084009B Gh secretagogues and uses thereof |
| 09/20/2011 | US8022220 Process for production of piperidine derivatives |
| 09/20/2011 | US8022182 Truncated BAFF receptors |
| 09/20/2011 | US8022176 FAS peptide mimetics and uses thereof |
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021834 Use of microparticles combined with submicron oil-in-water emulsions |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 09/20/2011 | CA2536632C Therapy-enhancing glucan |
| 09/20/2011 | CA2516233C 2-propylidene-19-nor-vitamin d compounds |
| 09/20/2011 | CA2510596C Dendritic cell line |
| 09/20/2011 | CA2506068C Pharmaceutical composition containing sfcyr iib or sfcyr iii |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2473209C Stimulation of the immune system with polydextrose |
| 09/20/2011 | CA2468552C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112687A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |